anagenics-logoanagenics-logoanagenics-logoanagenics-mobile-24
  • Home
  • About
    • About Anagenics
    • Board of Directors
  • Divisions
    • Our Divisions
    • Beauty
    • Brands
      • évolis®
      • Uspa
  • Investors
    • Investor Centre
    • ASX Announcements
      • 2025
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
    • Financial Information & Reports
    • Share Registry Information
    • Analyst Coverage
    • Share Information
    • Anagenics in the media
    • Newsletter Archive
  • Corporate Governance
    • Corporate Governance
    • Board Charter
    • Code of Conduct
    • Policies
    • Audit Committee Charter
    • Nomination and Remuneration Committee Charter
    • Performance Evaluation Process
    • Corporate Code of Conduct
    • Environmental, Social and Governance Statement
✕

Newsletter Archive

  • Home
  • Investor Centre
  • Newsletter Archive
Date Newsletter
23/12/2020 Investor Newsletter December 2020
15/05/2020 Cellmid’s statement in response to media article
22/04/2020 Cellmid information on Wondfo SARS-CoV-2 Antibody test
21/04/2020 Call for volunteers! ATLAS study
01/07/2019 Investor Newsletter July 2019
03/03/2019 Investor Newsletter March 2019
21/12/2018 2018 Cellmid Investor Newsletter
03/09/2018 Investor Newsletter September 2018

 

 

Anagenics Limited (ASX: AN1)

Suite 204, Level 2
55 Clarence Street
Sydney NSW 2000
Australia

Today’s Share Price

Careers | Privacy Policy | Contact Us

© 2023 Anagenics Limited. All Rights Reserved. ABN 69 111 304 119.